Metraipolis › archive › dc_ef353f653a99
Olanzapine for Extended-Release Injectable Suspension for Subcutaneous Use (TV-44749) Designed to Avoid the Risk of PDSS: In Vitro Release Studies in Human… — Europe PMC PMID:42198294
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42198294
- DOI
- 10.3390/pharmaceutics18050601
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T09:36:30.919Z
- SHA-256 of the archived text
90edf30fe1794b2e85c93e2468931e3addba0836ea1763dc2eef991374ef01ee- Stable URL of this page
https://metraipolis.com/documento/dc_ef353f653a99
How to cite
Olanzapine for Extended-Release Injectable Suspension for Subcutaneous Use (TV-44749) Designed to Avoid the Risk of PDSS: In Vitro Release Studies in Human… — Europe PMC PMID:42198294 — Europe PMC (en), https://europepmc.org/article/MED/42198294 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef353f653a99 (Metraipolis archive dc_ef353f653a99, sha256 90edf30fe1794b2e85c93e2468931e3addba0836ea1763dc2eef991374ef01ee)
BibTeX
@misc{dcef353f653a99,
title = {Olanzapine for Extended-Release Injectable Suspension for Subcutaneous Use (TV-44749) Designed to Avoid the Risk of PDSS: In Vitro Release Studies in Human… — Europe PMC PMID:42198294},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42198294},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef353f653a99; sha256 90edf30fe1794b2e85c93e2468931e3addba0836ea1763dc2eef991374ef01ee},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42198294. Agents can read the archived copy with the MCP tool read_document.